packageLecanemab

lecanemab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lecanemab is a monoclonal antibody used to treat Alzheimer's disease. It is authorised in the European Union and is an approved anti-dementia medicine, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q56274769 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lecanemab
ATC codes:N06DX04
DrugBank:DB14580
Wikidata:Q56274769
molar mass:150000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown